Table 7

Risk Assessment: Post-Revascularization (PCI or CABG)

IndicationAppropriateness Score (1–9)
Symptomatic
35.
  • Evaluation of chest pain syndrome

  • Not in the early post-procedure period

A (8)
Asymptomatic
36.
  • Less than 5 years after CABG

I (2)
37.
  • Asymptomatic (e.g., silent ischemia) prior to previous revascularization

  • Greater than or equal to 5 years after CABG

U (6)
38.
  • Symptomatic prior to previous revascularization

  • Greater than or equal to 5 years after CABG

U (5)
39.
  • Asymptomatic (e.g., silent ischemia) prior to previous revascularization

  • Less than 2 years after PCI

I (3)
40.
  • Symptomatic prior to previous revascularization

  • Less than 2 years after PCI

I (2)
41.
  • Asymptomatic (e.g., silent ischemia) prior to previous revascularization

  • Greater than or equal to 2 years after PCI

U (5)
  • The ranking of this indication as inappropriate is different from that given to similar but not identical indications in previously published appropriateness criteria. The ratings were done in accordance with established ACCF methodology. Furthermore, the Technical Panel for each modality operated independently without allowance and with discouragement for intermodality comparisons. Discrepant scores may be related to rating variability, differing Technical Panel composition, maturation of the appropriateness criteria process, or perceived differences in appropriateness.